posted on May, 13 2011 @ 11:44 PM
reply to post by alfa1
Originally posted by alfa1
Did you read the comments in the article (which is four years old now)?
Lauren, 97 minutes ago
If you look at the original paper, you would find that it has been cited in other publications 229 times since 2007. HARDLY 'not being noticed' from
a scientific perspective. And clinical trials from benchtop to patients will take YEARS and lots of funding. Abstract:
David 54 minutes ago
Actually this is not a joke. I had cancer, my oncologist at Baylor hospital knew about DCA... Two years later and I am still completely cured. It
doesn't work on all types of cancer
Even the website cancer.org (The American Cancer Society) says
DCA has been tested in humans on a small scale for rare diseases of metabolism (energy production), but has recently shown some promise in the lab
for cancer treatment. This has led some people with cancer to try taking DCA on their own. DCA is known to cause nerve and liver damage, as well as
some other side effects. It may also be able to cause cancer in humans, but that has not been proven. At this time, clinical trials (studies on
human volunteers) have just been started to find out if DCA might be helpful against cancer. No human studies have been completed yet, so it is
unclear how or whether it might help, or what the proper dose might be.
I have quoted most of your earlier post, hoping that it will stop a few people from being misled by the conspiracy mugs and panic-spreaders who infest
this site. Your post shows exactly who has their heads up where. The scientific community is not
ignorant of DCA and the pharmaceuticals
industry is not
suppressing research or killing off researchers*. The wannabelievers are, as usual, dead wrong.
As you say, research is ongoing. In fact, the University of Alberta web site now has an
update about DCA research on human subjects
, which anybody who was
genuinely interested in the subject
rather than in giving himself a thrill by sounding off against ‘Big Pharma’ and the ‘mainstream
media’ could have found with three minutes’ googling.
DCA has promise, but not as much as the OP article makes out; it also has potentially deadly side-effects and is not as effective – in its present
form, at least – as touted. From the above-linked update:
In the 5 patients tested, the drug took 3 months to reach blood levels high enough to alter the tumor's metabolism. At those levels, there were
no significant adverse effects. However, at some of the higher doses tested, DCA caused nerve malfunction, i.e. numbing of toes and fingers.
Importantly, in some patients there was also evidence for clinical benefit, with the tumors either regressing in size or not growing further during
the 18 month study.
Thanks for being a lonely voice of sanity in a jungle of ignorance, hysteria and stupidity.
*They’re just not funding it, which makes sense, since there is no profit to them in it.